{"protocolSection":{"identificationModule":{"nctId":"NCT02283294","orgStudyIdInfo":{"id":"PRO00019754"},"organization":{"fullName":"University of South Florida","class":"OTHER"},"briefTitle":"Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation","officialTitle":"Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation","acronym":"AREST"},"statusModule":{"statusVerifiedDate":"2018-12","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-04","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-06","type":"ACTUAL"},"completionDateStruct":{"date":"2019-06","type":"ACTUAL"},"studyFirstSubmitDate":"2014-10-29","studyFirstSubmitQcDate":"2014-10-31","studyFirstPostDateStruct":{"date":"2014-11-05","type":"ESTIMATED"},"resultsFirstSubmitDate":"2021-07-07","resultsFirstSubmitQcDate":"2021-11-03","resultsFirstPostDateStruct":{"date":"2021-11-30","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-11-03","lastUpdatePostDateStruct":{"date":"2021-11-30","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University of South Florida","class":"OTHER"},"collaborators":[{"name":"Bristol-Myers Squibb","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of this study is to evaluate if Apixaban will decrease the complication of having another stroke for people who have atrial fibrillation if initiated earlier than standard of care.","detailedDescription":"This is an Open label, randomized, active control, parallel-group pilot trial to examine the effect of initiation of APIXABAN at days 0-3 (TIA), days 3-5 (small stroke) and days 7-9 (medium stroke) to decrease fatal and/or recurrent stroke/TIA in 120 subjects who have suffered a recent( 0 to 48 hours from symptoms) TIA, or small to medium ischemic stroke compared to standard of care warfarin treatment regimen. Subjects will be randomly assigned in a 1:1 ratio to one of two treatment arms (apixaban or warfarin). Subjects will be followed for a total of 180 days during from screening through monthly follow-up visits."},"conditionsModule":{"conditions":["Transient Ischemic Attack","Stroke","Atrial Fibrillation"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":91,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Apixaban","type":"EXPERIMENTAL","description":"Apixaban twice a day for 180 days with drug initiation day 0-3 (TIA), day 3-5(small stroke) or day 7- 9 (medium stroke) respectively","interventionNames":["Drug: Apixaban"]},{"label":"Warfarin","type":"ACTIVE_COMPARATOR","description":"standard of care warfarin starting at day 7±5 (TIA) or day 14 ±5 (small to medium ischemic stroke).","interventionNames":["Drug: Warfarin"]}],"interventions":[{"type":"DRUG","name":"Apixaban","armGroupLabels":["Apixaban"]},{"type":"DRUG","name":"Warfarin","armGroupLabels":["Warfarin"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With a Composite Endpoint of Fatal Stroke, Recurrent Ischemic Stroke, or TIA","timeFrame":"180 days"}],"secondaryOutcomes":[{"measure":"Number of Participants With an Intracranial Hemorrhage Assessed by MRI/CT","timeFrame":"180 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Signed Written Informed Consent\n2. Males and Females over 18 years of age.\n3. History of Nonvalvular Atrial Fibrillation (NVAF) by documentation in the medical history or newly diagnosed nonvalvular Atrial Fibrillation at time of study randomization by ECG, device or telemetry .\n4. Diagnosis of TIA or small or medium ischemic stroke 0 to 48 hours from signs or symptoms.\n5. Women of child-bearing potential must use a reliable method of contraception and must provide a negative pregnancy test at entry into the study and within 24 hours of study treatment initiation.\n6. WOCBP must agree to follow instructions for method(s) of contraception for the duration of treatment with study drug Apixaban plus 5 half-lives (approximately 3 days) plus 30 days (duration of ovulatory cycle) for a total of 33 days post-treatment completion.\n7. Males who are sexually active with WOCBP must agree to follow instructions for method(s) of contraception for the duration of treatment with Apixaban plus 5 half-lives (approximately 3 days) plus 90 days (duration of sperm turnover) for a total of 93 days post-treatment completion.\n8. Azoospermic males and WOCBP who are continuously not heterosexually active are exempt from contraceptive requirements. However they must still undergo pregnancy testing as described in this section.\n\nInvestigators shall counsel WOCBP and male subjects who are sexually active with WOCBP on the importance of pregnancy prevention and the implications of an unexpected pregnancy Investigators shall advise WOCBP and male subjects who are sexually active with WOCBP on the use of highly effective methods of contraception. Highly effective methods of contraception have a failure rate of \\< 1% when used consistently and correctly.\n\nAt a minimum, subjects must agree to the use of one method of highly effective contraception as listed below:\n\nHIGHLY EFFECTIVE METHODS OF CONTRACEPTION\n\n* Male condoms with spermicide\n* Hormonal methods of contraception including combined oral contraceptive pills, vaginal ring, injectables, implants and intrauterine devices (IUDs) such as Mirena by WOCBP subject or male subject's WOCBP partner. Female partners of male subjects participating in the study may use hormone based contraceptives as one of the acceptable methods of contraception since they will not be receiving study drug\n* IUDs, such as ParaGard™\n* Tubal ligation\n* Vasectomy.\n* Complete Abstinence\n\nExclusion Criteria:\n\n1. Hemorrhagic stroke\n2. Large ischemic stroke\n3. History of major bleeding within the last 6 months from time of subject enrollment (e.g. GI bleed).\n4. History of intracranial bleed\n\n   a. Traumatic intracranial bleed within one year of randomization. (Traumatic ICH greater than one year of randomization is not an exclusion).\n5. Current or history of bleeding disorders (e.g. blood dycrasias)\n6. Blood Pressure of 180/100 mmHg on hypertensive therapy day of randomization per PI discretion 20.\n7. Current illicit drug use and/or chronic alcohol use per PI discretion.\n8. Severe liver disease (AST/ALT 2x upper limit).\n9. Patients with kidney disease meeting criteria to take 2.5 mg twice daily who are taking strong dual inhibitors of CYP3A4 and P-glycoprotein (e.g. ketoconazole, itraconazole, ritonavir, clarithromycin) .\n10. Any other suspected etiology for stroke (e.g. ipsilateral carotid disease).\n11. Greater than 3 Cerebral Micro-bleeds (CMB) on gradient recovery echo (GRE) or evidence of intracranial hemorrhage on CT at time of randomization. (SWI sequencing may be used if GRE sequencing is not obtainable)\n12. Therapeutically anti-coagulated at time of admission (INR at admission greater than 2.0 on warfarin or took two consecutive doses of NOAC).\n13. Absolute indication for use of warfarin only.( e.g. Mechanical Valve)\n14. Absolute indication for anticoagulation prior to randomization window. (e.g. DVT)\n15. Hemoglobin less than 9 gm/dl and/or platelet count less than 100 K/uL.\n16. Requires dual antiplatelet therapy.\n17. Daily use of NSAIDS\n18. Pregnancy or lactation.\n19. Any use of an investigational product within the past 30 days.\n20. Prisoners or subjects who are involuntarily incarcerated.\n21. Subjects who are compulsorily detained for treatment of either a psychiatric or physical (eg, infectious disease) illness.\n22. Concurrent participation in another clinical study where use of an investigational product is used","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Michael Fradley, M.D.","affiliation":"University of South Florida, Department of Cardiovascular Sciences","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center","city":"Torrance","state":"California","zip":"90502","country":"United States","geoPoint":{"lat":33.83585,"lon":-118.34063}},{"facility":"Bayfront Health St Petersburg","city":"Saint Petersburg","state":"Florida","zip":"33701","country":"United States","geoPoint":{"lat":27.77086,"lon":-82.67927}},{"facility":"Tampa General Hospital","city":"Tampa","state":"Florida","zip":"33602","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"University of South Florida","city":"Tampa","state":"Florida","zip":"33602","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"University of Louisville","city":"Louisville","state":"Kentucky","zip":"40202","country":"United States","geoPoint":{"lat":38.25424,"lon":-85.75941}}]},"referencesModule":{"references":[{"pmid":"33626904","type":"DERIVED","citation":"Labovitz AJ, Rose DZ, Fradley MG, Meriwether JN, Renati S, Martin R, Kasprowicz T, Murtagh R, Kip K, Beckie TM, Stoddard M, Bozeman AC, McTigue T, Kirby B, Tran N, Burgin WS; AREST Investigators. Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial. Stroke. 2021 Apr;52(4):1164-1171. doi: 10.1161/STROKEAHA.120.030042. Epub 2021 Feb 25."},{"pmid":"31620067","type":"DERIVED","citation":"Rose DZ, Meriwether JN, Fradley MG, Renati S, Martin RC, Kasprowicz T, Patel A, Mokin M, Murtagh R, Kip K, Bozeman AC, McTigue T, Hilker N, Kirby B, Wick N, Tran N, Burgin WS, Labovitz AJ. Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation-A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation. Front Neurol. 2019 Sep 20;10:975. doi: 10.3389/fneur.2019.00975. eCollection 2019."}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Ninety one patients were enrolled/consented into the study. Three patients of the 91 consented did not meet one or more of the inclusion/exclusion criteria and were excluded prior to randomization assignment.","groups":[{"id":"FG000","title":"Apixaban","description":"Apixaban twice a day for 180 days with drug initiation day 0-3 (TIA), day 3-5(small stroke) or day 7- 9 (medium stroke) respectively\n\nApixaban"},{"id":"FG001","title":"Warfarin","description":"standard of care warfarin starting at day 7±5 (TIA) or day 14 ±5 (small to medium ischemic stroke).\n\nWarfarin"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","comment":"Started indicates randomized to medication assignment. This does not necessarily indicate patient started the medication they were randomized to.","achievements":[{"groupId":"FG000","numSubjects":"41"},{"groupId":"FG001","numSubjects":"47"}]},{"type":"Received Allocated Treatment Intervention","achievements":[{"groupId":"FG000","numSubjects":"38"},{"groupId":"FG001","numSubjects":"31"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"38"},{"groupId":"FG001","numSubjects":"39"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"8"}]}],"dropWithdraws":[{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"6"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}]},{"type":"Thrombus on transesophageal echocardiogram","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Apixaban","description":"Apixaban twice a day for 180 days with drug initiation day 0-3 (TIA), day 3-5(small stroke) or day 7- 9 (medium stroke) respectively\n\nApixaban"},{"id":"BG001","title":"Warfarin","description":"standard of care warfarin starting at day 7±5 (TIA) or day 14 ±5 (small to medium ischemic stroke).\n\nWarfarin"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"88"}]}],"measures":[{"title":"Age, Categorical","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"25"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"35"},{"groupId":"BG002","value":"63"}]}]}]},{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"72.6","spread":"14.9"},{"groupId":"BG001","value":"74.3","spread":"10.5"},{"groupId":"BG002","value":"73.5","spread":"12.7"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"49"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"39"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Black","categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"12"}]}]},{"title":"Hispanic","categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"9"}]}]},{"title":"Non-Hispanic White","categories":[{"measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"35"},{"groupId":"BG002","value":"66"}]}]},{"title":"Other","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"88"}]}]}]},{"title":"Hypertension","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"38"},{"groupId":"BG001","value":"46"},{"groupId":"BG002","value":"84"}]}]}]},{"title":"Hyperlipidemia","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"58"}]}]}]},{"title":"Coronary artery disease (CAD)","description":"Inclusive of history of untreated myocardial infarction, prior stenting, and prior coronary artery bypass graft. Does not include non-obstructive coronary disease.","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"31"}]}]}]},{"title":"Diabetes Mellitus","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"32"}]}]}]},{"title":"Peripheral Artery Disease","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"13"}]}]}]},{"title":"Prior Stroke","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"19"}]}]}]},{"title":"Prosthetic Heart Valve / Valve Replacement","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"5"}]}]}]},{"title":"Thyroid Disease","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"22"}]}]}]},{"title":"Obstructive Sleep Apnea","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"12"}]}]}]},{"title":"Congestive Heart Failure Symptoms","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"12"}]}]}]},{"title":"Past Medical History Left Ventricular Ejection Fraction < 40%","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"19"}]}]}]},{"title":"Chronic Kidney Disease Stage 3","description":"glomerular filtration rate 30-59 mL/min/1.73 m\\^2","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"22"}]}]}]},{"title":"Chronic Kidney Disease Stage 4","description":"glomerular filtration rate 15-29 mL/min/1.73 m\\^2","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}]}]}]},{"title":"Chronic Kidney Disease Stage 5","description":"glomerular filtration rate \\<15 or on dialysis","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}]}]},{"title":"Transient Ischemic Attack","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"7"}]}]}]},{"title":"Thromboembolism History","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"}]}]}]},{"title":"New Onset Atrial Fibrillation","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"28"}]}]}]},{"title":"Prior Use of Anticoagulation within last 3 months","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"14"}]}]}]},{"title":"Former Tobacco Use History","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"23"}]}]}]},{"title":"Former Alcohol Use History","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}]}]}]},{"title":"Former Illegal Drug Use History","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}]}]},{"title":"Height","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"m","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1.67","spread":"0.11"},{"groupId":"BG001","value":"1.712","spread":"0.14"},{"groupId":"BG002","value":"1.69","spread":"0.13"}]}]}]},{"title":"Weight","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"kg","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"82.10","spread":"24.09"},{"groupId":"BG001","value":"88.08","spread":"24.73"},{"groupId":"BG002","value":"85.29","spread":"24.48"}]}]}]},{"title":"Body Mass Index","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"kg/m^2","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29.15","spread":"6.68"},{"groupId":"BG001","value":"30.05","spread":"7.60"},{"groupId":"BG002","value":"29.63","spread":"7.16"}]}]}]},{"title":"Body Surface Area","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"m^2","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1.90","spread":"0.28"},{"groupId":"BG001","value":"1.99","spread":"0.31"},{"groupId":"BG002","value":"1.95","spread":"0.30"}]}]}]},{"title":"Heart Rate","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"bpm","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"76.56","spread":"14.46"},{"groupId":"BG001","value":"76.62","spread":"16.61"},{"groupId":"BG002","value":"76.60","spread":"15.56"}]}]}]},{"title":"Systolic Blood Pressure","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"mmHg","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"130.85","spread":"18.64"},{"groupId":"BG001","value":"134.53","spread":"20.13"},{"groupId":"BG002","value":"132.82","spread":"19.43"}]}]}]},{"title":"Current Tobacco Use","description":"Daily Use","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"4"}]}]}]},{"title":"Occasional Tobacco Use","description":"Less than daily user","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}]}]},{"title":"Current Alcohol Use","description":"\\>/= 1 drink per day (1 drink = 12 ounces of regular beer, 5 ounces of wine, or 1.5 ounces of distilled spirits)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"12"}]}]}]},{"title":"Occasional Alcohol Use","description":"\\<1 drink per day (1 drink = 12 ounces of regular beer, 5 ounces of wine, or 1.5 ounces of distilled spirits)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"17"}]}]}]},{"title":"Diastolic Blood Pressure","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"mmHg","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"74.07","spread":"17.76"},{"groupId":"BG001","value":"70.26","spread":"19.50"},{"groupId":"BG002","value":"72.03","spread":"18.70"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With a Composite Endpoint of Fatal Stroke, Recurrent Ischemic Stroke, or TIA","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"180 days","groups":[{"id":"OG000","title":"Apixaban","description":"Apixaban twice a day for 180 days with drug initiation day 0-3 (TIA), day 3-5(small stroke) or day 7- 9 (medium stroke) respectively\n\nApixaban"},{"id":"OG001","title":"Warfarin","description":"Standard of care warfarin starting at day 7±5 (TIA) or day 14 ±5 (small to medium ischemic stroke).\n\nWarfarin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"47"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"12"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With an Intracranial Hemorrhage Assessed by MRI/CT","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"180 days","groups":[{"id":"OG000","title":"Apixaban","description":"Apixaban twice a day for 180 days with drug initiation day 0-3 (TIA), day 3-5(small stroke) or day 7- 9 (medium stroke) respectively\n\nApixaban"},{"id":"OG001","title":"Warfarin","description":"standard of care warfarin starting at day 7±5 (TIA) or day 14 ±5 (small to medium ischemic stroke).\n\nWarfarin"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"47"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"210 +/- 10 days","description":"Adverse event assessment was performed at each of the patient follow up visits at baseline, day 14, day 30, day 60, day 120, day 150, day 180, and day 210. At each follow up visit, patients were evaluated by study coordinator, cardiologist, and neurologist. A physical exam, patient interview, electrocardiogram, and review of patient records were performed. Labs were evaluated for clinical significance at day 30, day 90, and day 180 visits.","eventGroups":[{"id":"EG000","title":"Apixaban","description":"Apixaban twice a day for 180 days with drug initiation day 0-3 (TIA), day 3-5(small stroke) or day 7- 9 (medium stroke) respectively\n\nApixaban","deathsNumAffected":2,"deathsNumAtRisk":41,"seriousNumAffected":11,"seriousNumAtRisk":41,"otherNumAffected":36,"otherNumAtRisk":41},{"id":"EG001","title":"Warfarin","description":"standard of care warfarin starting at day 7±5 (TIA) or day 14 ±5 (small to medium ischemic stroke).\n\nWarfarin","deathsNumAffected":4,"deathsNumAtRisk":47,"seriousNumAffected":14,"seriousNumAtRisk":47,"otherNumAffected":41,"otherNumAtRisk":47}],"seriousEvents":[{"term":"Pancreatic Cancer","organSystem":"Endocrine disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Third Degree AV Block","organSystem":"Cardiac disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Fatal Stroke","organSystem":"General disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":47}]},{"term":"Worsening Congestive Heart Failure","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Left Hip Fracture","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Worsening Atrial Fibrillation","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Symptomatic Hypotension","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Symptomatic PH1 Hemorrhagic Transformation","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Rhabdomyolysis","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"TIA","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"GI Bleed","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Small Bowel Obstruction","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Pancolitis","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Acute Encephalopathy","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Ovarian Cyst","organSystem":"Reproductive system and breast disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Second Digit Right Foot Amputation","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Recurrent Stroke","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":41},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":47}]},{"term":"Back Fracture","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Worsening Back Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bilateral Leg Weakness / Trouble with Ambulation","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Right Hip Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Altered Mental Status","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Metabolic Encephalopathy","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Shortness of Breath","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Symptomatic Anemia","organSystem":"Blood and lymphatic system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Ostectomy Left Foot","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]}],"otherEvents":[{"term":"Fatigue","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":41},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":47}]},{"term":"Dizziness","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":10,"numAffected":9,"numAtRisk":47}]},{"term":"Shortness of Breath","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":47}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":41},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":47}]},{"term":"Sinus Bradycardia","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Back Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":47}]},{"term":"Intermittent Headaches","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":41},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":47}]},{"term":"Urinary Tract Infection","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":41},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":47}]},{"term":"Asymptomatic Bleed","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":41},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":47}]},{"term":"Fever","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Difficulty Finding Words","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Intermittent Cognitive Impairment","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Upper Respiratory Infection","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Acute Kidney Injury","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bilateral Lower Extremity Edema","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":10,"numAtRisk":41},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":47}]},{"term":"Intermittent Leg Cramping","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Body / Muscle Aches","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":47}]},{"term":"Back Pain with Ambulation","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Right Hip Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Cough","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":47}]},{"term":"Dry Mouth","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Altered Sense of Taste","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Left Calf Sore","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Hypertension","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Lower Back Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Palpitations","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Cold Symptoms","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Sore Throat","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Worsening Hearing Loss","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Gout Right Foot","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Diarrhea","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Ataxia","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Right or Left Sided Weakness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Shakiness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Intermittent Lightheadedness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Blood Clot in Descending Aorta","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bronchitis","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Pleuritic Chest Pain","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Decreased Appetite","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Generalized Weakness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Chest Pain or Tightness","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":41},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":47}]},{"term":"Staph Infection Right Foot","organSystem":"Infections and infestations","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Pneumonia","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Hemoptysis","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Left Foot Cellulitis","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Intermittent Cardiac Pauses","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Fall without Injury","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":7,"numAtRisk":41},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":47}]},{"term":"Left Foot Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Unsteady Gait","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Intermittent Left Leg Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Erectile Dysfunction","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Pulmonary Edema","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Leukocytosis","organSystem":"Blood and lymphatic system disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Supratherapeutic INR","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":29,"numAffected":9,"numAtRisk":47}]},{"term":"Left Eye Subconjunctival Hemorrhage","organSystem":"Eye disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bruising","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":12,"numAffected":8,"numAtRisk":47}]},{"term":"Left Ankle Swelling","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Vaginal Bleeding","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Right Ankle Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Hypotension","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Hyponatremia","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Right Foot Droop","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Sensory Peripheral Neuropathy","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Fall with Injury","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Abrasions","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":8,"numAffected":6,"numAtRisk":47}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Orthostatic Loss of Consciousness","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Acute Renal Failure","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Hypokalemia","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Hyperkalemia","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Facial and Neck Swelling","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Left Lower Facial Numbness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Nonsustained Ventricular Tachycardia","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bilateral Lower Extremity Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Abnormal Liver Tests","organSystem":"Hepatobiliary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Parathesia","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Total Bilirubin Elevated","organSystem":"Hepatobiliary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Supraventricular Tachycardia","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Small Benign Cysts, Right Hepatic Lobe","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Muscle Spasticity","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Upper Extremity Stiffness","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Left Lower Extremity Edema","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Vertigo","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Right Chest Basal Cell Removal","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Upper Left Back Basal Cell Removal","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Gastrointestinal Upset","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Left Middle Finger Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Sinus Infection","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bibasilar Rales","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Pacemaker Implant for Arrhythmia","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Diaphoretic","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Responsive Only to Painful Stimuli","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Right Temporal Laceration","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Chronic Obstructive Pulmonary Disease Exacerbation","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Slurred Speech","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Scalp Hematoma","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Blood in Sputum","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Minor Head Injury","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Right Great Toenail Removal Status Post Toe Injury","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Left Hamstring Injury","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Coarse Breath Sounds","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Wheezing","organSystem":"Respiratory, thoracic and mediastinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":47}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Esophagitis","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Actinic Keratosis Left Forearm","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Squamous Cell Carcinoma","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Skin Peeling","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Gastrointestinal Bleed","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Acute Gastric Ulcer with Hemorrhage","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Hematuria","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Diploplia","organSystem":"Eye disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Blood in Semen","organSystem":"Renal and urinary disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Abdominal Distention","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":47}]},{"term":"Motor Vehicle Accident with Injury","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Right Flank Pain","organSystem":"Musculoskeletal and connective tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"White Tongue","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Skin Lesion to Nose","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Generalized Body Numbness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Thrombus in Appendage","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Syncopal Episode","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Viral Illness","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Ear and Nose Infection","organSystem":"Infections and infestations","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bladder Infection","organSystem":"Infections and infestations","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Dehydration","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Midpelvic Mass","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":47}]},{"term":"Fluid Overload","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Heart Failure with Preserved Ejection Fraction","organSystem":"Cardiac disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Right Lower Extremity Blister","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Bilateral Lower Extremity Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":47}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"David Rose, MD","organization":"University of South Florida","email":"drose1@usf.edu","phone":"813-259-8577"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2020-07-13","uploadDate":"2021-07-06T15:51","filename":"Prot_SAP_000.pdf","size":1132914}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000002546","term":"Ischemic Attack, Transient"},{"id":"D000083262","term":"Embolic Stroke"},{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000083242","term":"Ischemic Stroke"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M14540","name":"Recurrence","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M5485","name":"Ischemic Attack, Transient","asFound":"Transient Ischemic Attack","relevance":"HIGH"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M2403","name":"Embolic Stroke","asFound":"Embolic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000014859","term":"Warfarin"},{"id":"C000522181","term":"Apixaban"}],"ancestors":[{"id":"D000000925","term":"Anticoagulants"},{"id":"D000065427","term":"Factor Xa Inhibitors"},{"id":"D000000991","term":"Antithrombins"},{"id":"D000015842","term":"Serine Proteinase Inhibitors"},{"id":"D000011480","term":"Protease Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M288142","name":"Apixaban","asFound":"Extraction","relevance":"HIGH"},{"id":"M17292","name":"Warfarin","asFound":"Third","relevance":"HIGH"},{"id":"M3934","name":"Anticoagulants","relevance":"LOW"},{"id":"M30203","name":"Factor Xa Inhibitors","relevance":"LOW"},{"id":"M3997","name":"Antithrombins","relevance":"LOW"},{"id":"M3996","name":"Antithrombin III","relevance":"LOW"},{"id":"M14033","name":"Protease Inhibitors","relevance":"LOW"},{"id":"M18081","name":"Serine Proteinase Inhibitors","relevance":"LOW"},{"id":"M19299","name":"HIV Protease Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"T18","name":"Serine","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnCoag","name":"Anticoagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Infe","name":"Anti-Infective Agents"},{"abbrev":"AA","name":"Amino Acids"}]}},"hasResults":true}